IP Verse

Use Of Dpp Iv Inhibitors - EP2397142B1

PatentPatent Analysis

EP2397142

BOEHRINGER INGELHEIM
Application Number
EP11179908A
Filing Date
May 3, 2007
Status
Granted And Under Opposition
Jun 24, 2022
Grant Date
Jul 27, 2022
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2488145B1
EP3150200B1
EP2395968B1

Bibliography

The patent EP2397142B1 was granted to Boehringer Ingelheim on Jul 27, 2022 following the initial filing on May 3, 2007 under the application number EP11179908A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

GENERICS UKApr 27, 2023ADMISSIBLE
STADA ARZNEIMITTELApr 26, 2023ADMISSIBLE
KRAUS & LEDERER PARTGMBBApr 25, 2023ADMISSIBLE
POLPHARMAApr 19, 2023ADMISSIBLE
SANDOZApr 13, 2023ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents